Anlotinib plus chemotherapy as first-line therapy for gastrointestinal tumor patients with unresectable liver metastasis: Updated results from a multi-cohort, multi-center phase II trial ALTER-G-001-cohort A

J. Wu, L. Zhu, C. Zhou,M. Shi,J. Chen, L. Zhao, Z. Han, C. Wang,J. Jiang, J. Yan,X. Wei, Y. Mao, X. Yang, Z. Qin, X. Tang, J. Zhang

Annals of Oncology（2023）

引用 0|浏览0